DrugPatentWatch Database Preview
Zydus Pharms Usa Company Profile
What is the competitive landscape for ZYDUS PHARMS USA, and when can generic versions of ZYDUS PHARMS USA drugs launch?
ZYDUS PHARMS USA has one hundred and eighty-seven approved drugs.
There is one US patent protecting ZYDUS PHARMS USA drugs. There are nine tentative approvals on ZYDUS PHARMS USA drugs.
Summary for Zydus Pharms Usa
| US Patents: | 1 |
| Tradenames: | 155 |
| Ingredients: | 154 |
| NDAs: | 187 |
Drugs and US Patents for Zydus Pharms Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | DOXYCYCLINE | doxycycline hyclate | INJECTABLE;INJECTION | 207757-002 | Sep 28, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 208988-001 | Aug 22, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | METRONIDAZOLE | metronidazole | TABLET;ORAL | 206560-001 | Nov 16, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 078226-003 | Jul 9, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Zydus Pharms Usa Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011089623 | ➤ Sign Up |
| Japan | 2013516459 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Zydus Pharms Usa Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB98/037 | United Kingdom | ➤ Sign Up | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE) (GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS.; REGISTERED: CH 54 250.02 19970815; UK EU/1/97/046/001 19970827; UK EU/1/97/046/002 19970827; UK EU/1/97/046/003 19970827; UK EU/1/97/046/004 19970827; UK EU/1/97/046/005 19970827; UK EU/1/97/046/006 19970827; UK EU/1/97/046/007 19970827; UK EU/1/97/046/008 19970827; UK EU/1/97/046/009 19970827 |
| 1998 | Austria | ➤ Sign Up | PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214 |
| 00C/032 | Belgium | ➤ Sign Up | PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329 |
| /2001 | Austria | ➤ Sign Up | PRODUCT NAME: NATEGLINIDE; NAT. REGISTRATION NO/DATE: EU/1/01/174/001 - EU/1/01/174/021 20010403; FIRST REGISTRATION: LI 55401.01 - 02 20000928 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
